Guardian Pharmacy Services, Inc.
GRDN
$34.09
$1.163.52%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.44% | 20.05% | 14.76% | 19.57% | 20.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.44% | 20.05% | 14.76% | 19.57% | 20.46% |
| Cost of Revenue | 14.97% | 19.40% | 15.68% | 20.27% | 19.86% |
| Gross Profit | 27.42% | 22.74% | 11.19% | 16.78% | 22.95% |
| SG&A Expenses | -2.43% | -65.00% | 22.70% | 14.28% | 229.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.20% | -13.90% | 16.76% | 19.26% | 33.36% |
| Operating Income | 124.99% | 116.20% | -16.41% | 27.53% | -59.67% |
| Income Before Tax | 91.72% | 115.74% | -32.45% | 204.15% | 11.42% |
| Income Tax Expenses | 124.52% | 3,898.86% | -- | -- | -- |
| Earnings from Continuing Operations | 79.59% | 109.07% | -52.63% | 115.20% | -18.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -435.29% | 103.30% | 103.89% | 104.06% | 104.01% |
| Net Income | 75.19% | 108.72% | -32.66% | -- | -0.62% |
| EBIT | 124.99% | 116.20% | -16.41% | 27.53% | -59.67% |
| EBITDA | 96.95% | 122.89% | -10.23% | 22.31% | -52.23% |
| EPS Basic | 289.56% | 108.58% | -33.65% | -- | -- |
| Normalized Basic EPS | 124.45% | 114.84% | 78.19% | -- | -- |
| EPS Diluted | 288.70% | 108.40% | -34.84% | -- | -- |
| Normalized Diluted EPS | 125.90% | 114.54% | 74.97% | -- | -- |
| Average Basic Shares Outstanding | 2.06% | 1.60% | 1.48% | -- | -- |
| Average Diluted Shares Outstanding | 1.42% | 3.74% | 3.37% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |